Minerva Neurosciences, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Minerva Neurosciences, Inc. (NERV) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 5.34 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-08-09
- Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-06-30 was 5.34M shares, a 0.00% change year-over-year.
- Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 42.72M shares, a 0.00% change year-over-year.
- Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 5.34M shares.
- Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 42.72M shares, a 9.05% increase year-over-year.
- Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 39.01M shares, a 0.57% increase from fiscal 2018.
- Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 38.79M shares, a 2.25% increase from fiscal 2017.
- Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 37.94M shares, a 20.38% increase from fiscal 2016.
- Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 31.51M shares, a 34.61% increase from fiscal 2015.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | 5.34M shares 10-Q · filed 2022-08-09 | 5.34M shares 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | 42.72M shares 10-Q · filed 2022-05-04 | |||
| 2021-06-30 | 5.34M shares 10-Q · filed 2022-08-09 | 5.34M shares 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | 42.72M shares 10-Q · filed 2022-05-04 | |||
| 2020-03-31 | 39.18M shares 10-Q · filed 2021-05-12 | 39.11M shares derived: average of 2 quarters · filed 2021-05-12 | 39.08M shares derived: average of 3 quarters · filed 2021-05-12 | 39.07M shares derived: average of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | 39.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 39.03M shares derived: average of 2 quarters · filed 2020-03-09 | 39.03M shares derived: average of 3 quarters · filed 2020-03-09 | 39.01M shares 10-K · filed 2020-03-09 |
| 2019-09-30 | 39.03M shares 10-Q · filed 2019-11-04 | 39.03M shares derived: average of 2 quarters · filed 2019-11-04 | 39.01M shares 10-Q · filed 2019-11-04 | 38.98M shares derived: average of 4 quarters · filed 2020-05-04 |
| 2019-06-30 | 39.03M shares 10-Q · filed 2019-08-05 | 39.00M shares 10-Q · filed 2019-08-05 | 38.96M shares derived: average of 3 quarters · filed 2020-05-04 | 38.92M shares derived: average of 4 quarters · filed 2020-05-04 |
| 2019-03-31 | 38.97M shares 10-Q · filed 2020-05-04 | 38.93M shares derived: average of 2 quarters · filed 2020-05-04 | 38.88M shares derived: average of 3 quarters · filed 2020-05-04 | 38.85M shares derived: average of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | 38.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 38.84M shares derived: average of 2 quarters · filed 2020-03-09 | 38.81M shares derived: average of 3 quarters · filed 2020-03-09 | 38.79M shares 10-K · filed 2020-03-09 |
| 2018-09-30 | 38.78M shares 10-Q · filed 2019-11-04 | 38.77M shares derived: average of 2 quarters · filed 2019-11-04 | 38.76M shares 10-Q · filed 2019-11-04 | 38.75M shares derived: average of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | 38.75M shares 10-Q · filed 2019-08-05 | 38.75M shares 10-Q · filed 2019-08-05 | 38.74M shares derived: average of 3 quarters · filed 2019-08-05 | 39.27M shares derived: average of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | 38.75M shares 10-Q · filed 2019-05-06 | 38.73M shares derived: average of 2 quarters · filed 2019-05-06 | 39.45M shares derived: average of 3 quarters · filed 2019-05-06 | 38.77M shares derived: average of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | 38.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 39.80M shares derived: average of 2 quarters · filed 2019-03-12 | 38.77M shares derived: average of 3 quarters · filed 2019-03-12 | 37.94M shares 10-K · filed 2019-03-12 |
| 2017-09-30 | 40.88M shares 10-Q · filed 2018-11-05 | 38.80M shares derived: average of 2 quarters · filed 2018-11-05 | 37.68M shares 10-Q · filed 2018-11-05 | 36.96M shares derived: average of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | 36.72M shares 10-Q · filed 2018-08-02 | 36.05M shares 10-Q · filed 2018-08-02 | 35.66M shares derived: average of 3 quarters · filed 2018-08-02 | 35.44M shares derived: average of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | 35.37M shares 10-Q · filed 2018-05-03 | 35.12M shares derived: average of 2 quarters · filed 2018-05-03 | 35.02M shares derived: average of 3 quarters · filed 2018-05-03 | 33.54M shares derived: average of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | 34.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 34.84M shares derived: average of 2 quarters · filed 2018-03-12 | 32.94M shares derived: average of 3 quarters · filed 2018-03-12 | 31.51M shares 10-K · filed 2018-03-12 |
| 2016-09-30 | 34.81M shares 10-Q · filed 2017-11-06 | 31.96M shares derived: average of 2 quarters · filed 2017-11-06 | 30.39M shares 10-Q · filed 2017-11-06 | 28.97M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | 29.12M shares 10-Q · filed 2017-08-03 | 28.16M shares 10-Q · filed 2017-08-03 | 27.02M shares derived: average of 3 quarters · filed 2018-03-12 | 26.44M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | 27.20M shares 10-Q · filed 2017-05-04 | 25.97M shares derived: average of 2 quarters · filed 2018-03-12 | 25.55M shares derived: average of 3 quarters · filed 2018-03-12 | 25.34M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | 24.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 24.73M shares derived: average of 2 quarters · filed 2018-03-12 | 24.72M shares derived: average of 3 quarters · filed 2018-03-12 | 23.41M shares 10-K · filed 2018-03-12 |
| 2015-09-30 | 24.72M shares 10-Q · filed 2016-11-03 | 24.72M shares derived: average of 2 quarters · filed 2016-11-03 | 22.97M shares 10-Q · filed 2016-11-03 | 21.84M shares derived: average of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | 24.72M shares 10-Q · filed 2016-08-04 | 22.08M shares 10-Q · filed 2016-08-04 | 20.88M shares derived: average of 3 quarters · filed 2017-03-13 | 20.10M shares derived: average of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | 19.42M shares 10-Q · filed 2016-05-03 | 18.96M shares derived: average of 2 quarters · filed 2017-03-13 | 18.56M shares derived: average of 3 quarters · filed 2017-03-13 | 15.82M shares derived: average of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | 18.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | 18.13M shares derived: average of 2 quarters · filed 2017-03-13 | 14.62M shares derived: average of 3 quarters · filed 2017-03-13 | 12.72M shares 10-K · filed 2017-03-13 |
| 2014-09-30 | 17.75M shares 10-Q · filed 2015-11-05 | 12.68M shares derived: average of 2 quarters · filed 2015-11-05 | 10.80M shares 10-Q · filed 2015-11-05 | 9.36M shares derived: average of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | 7.60M shares 10-Q · filed 2015-08-05 | 7.26M shares 10-Q · filed 2015-08-05 | 6.56M shares derived: average of 3 quarters · filed 2015-08-05 | 5.94M shares derived: average of 4 quarters · filed 2015-08-05 |
| 2014-03-31 | 6.90M shares 10-Q · filed 2015-05-07 | 6.04M shares derived: average of 2 quarters · filed 2015-05-07 | 5.39M shares derived: average of 3 quarters · filed 2015-05-07 | 5.02M shares derived: average of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | 5.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | 4.63M shares derived: average of 2 quarters · filed 2015-03-26 | 4.39M shares derived: average of 3 quarters · filed 2015-03-26 | 4.19M shares 10-K · filed 2015-03-26 |
| 2013-09-30 | 4.09M shares 10-Q · filed 2014-11-06 | 4.00M shares derived: average of 2 quarters · filed 2014-11-06 | 3.86M shares 10-Q · filed 2014-11-06 | |
| 2013-06-30 | 3.92M shares 10-Q · filed 2014-08-07 | 3.74M shares 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |